Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Wendy Keitel
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Disorders
Procedures
Living Beings
Concepts & Ideas
Phenomena
Sign-in to see full Profile
Network (preview)
18
Couch, Robert
17
Cate, Thomas
14
Atmar, Robert
5
Edwards, Kathryn
5
El Sahly, Hana
5
Treanor, John
4
Ward, Joel
4
Edelman, Robert
4
Chang, Swei-Ju
4
Cherry, James
4
Barenkamp, Steve
3
Butel, Janet
3
Campbell, James
3
Greenberg, David
3
Greenberg, Stephen
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Wendy Keitel (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Keitel Wendy A; Dekker Cornelia L; Mink ChrisAnna; Campbell James D; Edwards Kathryn M; Patel Shital M; Ho Dora Y; Talbot Helen K; Guo Kuo; Noah Diana L; Hill Heather
Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults.
Vaccine 2009;27(47):6642-8.
-
2009: Couch Robert B; Atmar Robert L; Cate Thomas R; Quarles John M; Keitel Wendy A; Arden Nancy H; Wells Janet; Niño Diane; Wyde Philip R
Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans.
Vaccine 2009;27(39):5344-8.
-
2009: El Sahly H M; Atmar R L; Patel S M; Wells J M; Cate T; Ho M; Guo K; Pasetti M F; Lewis D E; Sztein M B; Keitel W A
Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans.
Vaccine 2009;27(36):4905-11.
-
2009: Keitel Wendy A; Treanor John J; El Sahly Hana M; Evans Thomas G; Kopper Scott; Whitlow Vanessa; Selinsky Cheryl; Kaslow David C; Rolland Alain; Smith Larry R; Lalor Peggy A
Evaluation of a plasmid DNA-based anthrax vaccine in rabbits, nonhuman primates and healthy adults.
Human vaccines 2009;5(8):536-44.
-
2009: Keitel Wendy A; Atmar Robert L
Vaccines for pandemic influenza: summary of recent clinical trials.
Current topics in microbiology and immunology 2009;333():431-51.
-
2009: Atmar Robert L; Keitel Wendy A
Adjuvants for pandemic influenza vaccines.
Current topics in microbiology and immunology 2009;333():323-44.
-
2008: Keitel Wendy A; Campbell James D; Treanor John J; Walter Emmanuel B; Patel Shital M; He Fenhua; Noah Diana L; Hill Heather
Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial.
The Journal of infectious diseases 2008;198(9):1309-16.
-
2008: Marano Nina; Plikaytis Brian D; Martin Stacey W; Rose Charles; Semenova Vera A; Martin Sandra K; Freeman Alison E; Li Han; Mulligan Mark J; Parker Scott D; Babcock Janiine; Keitel Wendy; El Sahly Hana; Poland Gregory A; Jacobson Robert M; Keyserling Harry L; Soroka Stephen D; Fox Sarah P; Stamper John L; McNeil Michael M; Perkins Bradley A; Messonnier Nancy; Quinn Conrad P;
Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial.
JAMA : the journal of the American Medical Association 2008;300(13):1532-43.
-
2008: Keitel Wendy A; Atmar Robert L; Nino Diane; Cate Thomas R; Couch Robert B
Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variants.
The Journal of infectious diseases 2008;198(7):1016-8.
-
2008: El Sahly Hana M; Keitel Wendy A
Clinical data on Fluarix: an inactivated split seasonal influenza vaccine.
Expert review of vaccines 2008;7(6):713-9.
-
2008: El Sahly Hana M; Keitel Wendy A
Pandemic H5N1 influenza vaccine development: an update.
Expert review of vaccines 2008;7(2):241-7.
-
2007: Keitel Wendy A; Atmar Robert L
Preparing for a possible pandemic: influenza A/H5N1 vaccine development.
Current opinion in pharmacology 2007;7(5):484-90.
-
2007: Atmar Robert L; Keitel Wendy A; Cate Thomas R; Munoz Flor M; Ruben Fred; Couch Robert B
A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults.
Vaccine 2007;25(29):5367-73.
-
2006: Atmar Robert L; Keitel Wendy A; Patel Shital M; Katz Jacqueline M; She Dewei; El Sahly Hana; Pompey Justine; Cate Thomas R; Couch Robert B
Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(9):1135-42.
-
2006: Keitel Wendy A
Recombinant protective antigen 102 (rPA102): profile of a second-generation anthrax vaccine.
Expert review of vaccines 2006;5(4):417-30.
-
2006: Ward Joel I; Cherry James D; Chang Swei-Ju; Partridge Susan; Keitel Wendy; Edwards Kathryn; Lee Martin; Treanor John; Greenberg David P; Barenkamp Stephen; Bernstein David I; Edelman Robert;
Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(2):151-7.
-
2006: Keitel Wendy A; Atmar Robert L; Cate Thomas R; Petersen Nancy J; Greenberg Stephen B; Ruben Fred; Couch Robert B
Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons.
Archives of internal medicine 2006;166(10):1121-7.
-
2005: Ward Joel I; Cherry James D; Chang Swei-Ju; Partridge Susan; Lee Hang; Treanor John; Greenberg David P; Keitel Wendy; Barenkamp Stephen; Bernstein David I; Edelman Robert; Edwards Kathryn;
Efficacy of an acellular pertussis vaccine among adolescents and adults.
The New England journal of medicine 2005;353(15):1555-63.
-
2004: Cherry James D; Chang Swei-Ju; Klein David; Lee Martin; Barenkamp Steve; Bernstein David; Edelman Robert; Decker Michael D; Greenberg David P; Keitel Wendy; Treanor John; Ward Joel I
Prevalence of antibody to Bordetella pertussis antigens in serum specimens obtained from 1793 adolescents and adults.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(11):1715-8.
-
2004: Le Thuan; Cherry James D; Chang Swei-Ju; Knoll Maria Deloria; Lee Martin L; Barenkamp Steve; Bernstein David; Edelman Robert; Edwards Kathryn M; Greenberg David; Keitel Wendy; Treanor John; Ward Joel I;
Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study.
The Journal of infectious diseases 2004;190(3):535-44.
-
2004: Amaya Rene A; Baker Carol J; Keitel Wendy A; Edwards Morven S
Healthy elderly people lack neutrophil-mediated functional activity to type V group B Streptococcus.
Journal of the American Geriatrics Society 2004;52(1):46-50.
-
2003: Ling Paul D; Vilchez Regis A; Keitel Wendy A; Poston David G; Peng Rong Sheng; White Zoe S; Visnegarwala Fehmida; Lewis Dorothy E; Butel Janet S
Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(9):1244-9.
-
2003: Walling Dennis M; Brown Abigail L; Etienne Wiguins; Keitel Wendy A; Ling Paul D
Multiple Epstein-Barr virus infections in healthy individuals.
Journal of virology 2003;77(11):6546-50.
-
2003: Ling Paul D; Lednicky John A; Keitel Wendy A; Poston David G; White Zoe S; Peng RongSheng; Liu Zhensheng; Mehta Satish K; Pierson Duane L; Rooney Cliona M; Vilchez Regis A; Smith E O'Brian; Butel Janet S
The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study.
The Journal of infectious diseases 2003;187(10):1571-80.
-
2003: Lednicky John A; Vilchez Regis A; Keitel Wendy A; Visnegarwala Fehmida; White Zoe S; Kozinetz Claudia A; Lewis Dorothy E; Butel Janet S
Polyomavirus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy.
AIDS (London, England) 2003;17(6):801-7.
-
2002: Keitel Wendy A
Repeated immunization of children with inactivated and live attenuated influenza virus vaccines: safety, immunogenicity, and protective efficacy.
Seminars in pediatric infectious diseases 2002;13(2):112-9.
-
2002: Lee Edwin A M; Palmer Dupeh R; Flanagan Katie L; Reece William H H; Odhiambo Kennedy; Marsh Kevin; Pinder Margaret; Gravenor Michael B; Keitel Wendy A; Kester Kent E; Diggs Carter; Kaslow David; Apostolopoulos V; Ballou W Ripley; Hill Adrian V S; Krzych Urszula; Plebanski Magdalena
Induction of T helper type 1 and 2 responses to 19-kilodalton merozoite surface protein 1 in vaccinated healthy volunteers and adults naturally exposed to malaria.
Infection and immunity 2002;70(3):1417-21.
-
2002: Treanor John; Keitel Wendy; Belshe Robert; Campbell James; Schiff Gilbert; Zangwill Ken; Wolff Mark; Klimov Alexander; Levandowski Roland; Lambert Linda
Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults.
Vaccine 2002;20(7-8):1099-105.
-
2001: Keitel W A; Cate T R; Nino D; Huggins L L; Six H R; Quarles J M; Couch R B
Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.
The Journal of infectious diseases 2001;183(2):329-332.
-
1999: Keitel W A; Kester K E; Atmar R L; White A C; Bond N H; Holland C A; Krzych U; Palmer D R; Egan A; Diggs C; Ballou W R; Hall B F; Kaslow D
Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid.
Vaccine 1999;18(5-6):531-9.
-
1999: Keitel W A; Muenz L R; Decker M D; Englund J A; Mink C M; Blumberg D A; Edwards K M
A randomized clinical trial of acellular pertussis vaccines in healthy adults: dose-response comparisons of 5 vaccines and implications for booster immunization.
The Journal of infectious diseases 1999;180(2):397-403.
-
1999: Keitel W A
Cellular and acellular pertussis vaccines in adults.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;28 Suppl 2():S118-23.
-
1999: Keitel W A; Edwards K M
Acellular pertussis vaccines in adults.
Infectious disease clinics of North America 1999;13(1):83-94, vi.
-
1997: Couch R B; Keitel W A; Cate T R
Improvement of inactivated influenza virus vaccines.
The Journal of infectious diseases 1997;176 Suppl 1():S38-44.
-
1997: Keitel W A; Cate T R; Couch R B; Huggins L L; Hess K R
Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period.
Vaccine 1997;15(10):1114-22.
-
1996: Keitel W A; Cate T R; Atmar R L; Turner C S; Nino D; Dukes C M; Six H R; Couch R B
Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly.
Clinical and diagnostic laboratory immunology 1996;3(5):507-10.
-
1996: Khan A S; Polezhaev F; Vasiljeva R; Drinevsky V; Buffington J; Gary H; Sominina A; Keitel W; Regnery H; Lonskaya N L; Doroshenko E; Gavrilov A; Ivakhov I; Arden N; Schonberger L B; Couch R; Kendal A; Cox N
Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren.
The Journal of infectious diseases 1996;173(2):453-6.
-
1995: Kilbourne E D; Couch R B; Kasel J A; Keitel W A; Cate T R; Quarles J H; Grajower B; Pokorny B A; Johansson B E
Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans.
Vaccine 1995;13(18):1799-803.
-
1995: Musher D M; Keitel W A
Severe paroxysmal coughing and pleuritic pain in an adult.
Hospital practice (1995) 1995;30(12):65-7.
-
1995: Atmar R L; Keitel W A; Cate T R; Quarles J M; Couch R B
Comparison of trivalent cold-adapted recombinant (CR) influenza virus vaccine with monovalent CR vaccines in healthy unselected adults.
The Journal of infectious diseases 1995;172(1):253-7.
-
1995: Keitel W A; Edwards K M
Pertussis in adolescents and adults: time to reimmunize?
Seminars in respiratory infections 1995;10(1):51-7.
-
1994: Keitel W A; Couch R B; Cate T R; Hess K R; Baxter B; Quarles J M; Atmar R L; Six H R
High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults.
Journal of clinical microbiology 1994;32(10):2468-73.
-
1994: Keitel W A; Bond N L; Zahradnik J M; Cramton T A; Robbins J B
Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines.
Vaccine 1994;12(3):195-9.
-
1993: Keitel W A; Couch R B; Quarles J M; Cate T R; Baxter B; Maassab H F
Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults.
The Journal of infectious diseases 1993;167(2):305-11.
-
1993: Keitel W; Couch R; Bond N; Adair S; Van Nest G; Dekker C
Pilot evaluation of influenza virus vaccine (IVV) combined with adjuvant.
Vaccine 1993;11(9):909-13.
-
1991: Glezen W P; Keitel W A; Taber L H; Piedra P A; Clover R D; Couch R B
Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978-1989.
American journal of epidemiology 1991;133(3):296-304.
-
1990: Atmar R L; Bloom K; Keitel W; Couch R B; Greenberg S B
Effect of live attenuated, cold recombinant (CR) influenza virus vaccines on pulmonary function in healthy and asthmatic adults.
Vaccine 1990;8(3):217-24.
-
1990: Keitel W A; Couch R B; Cate T R; Six H R; Baxter B D
Cold recombinant influenza B/Texas/1/84 vaccine virus (CRB 87): attenuation, immunogenicity, and efficacy against homotypic challenge.
The Journal of infectious diseases 1990;161(1):22-6.
-
1988: Keitel W A; Cate T R; Couch R B
Efficacy of sequential annual vaccination with inactivated influenza virus vaccine.
American journal of epidemiology 1988;127(2):353-64.
-
1986: Couch R B; Kasel J A; Glezen W P; Cate T R; Six H R; Taber L H; Frank A L; Greenberg S B; Zahradnik J M; Keitel W A
Influenza: its control in persons and populations.
The Journal of infectious diseases 1986;153(3):431-40.
-
1984: Kasel J A; Frank A L; Keitel W A; Taber L H; Glezen W P
Acquisition of serum antibodies to specific viral glycoproteins of parainfluenza virus 3 in children.
Journal of virology 1984;52(3):828-32.
Sign-in to see more
